肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

2020 ESMO临床实践指南：癌症患者骨健康

2020-08-05 欧洲肿瘤内科学会 Ann Oncol . 2020 Aug 5;

癌症患者

2020年8月，欧洲肿瘤内科学会(ESMO)发布了癌症患者骨健康指南，癌症本身及其治疗对骨骼健康影像很大，临床医生在治疗癌症患者时需要了解转移性疾病的多学科治疗减少骨损伤以及减少癌症治疗引起的正常骨损

中文标题：

2020 ESMO临床实践指南：癌症患者骨健康

英文标题：

BONE HEALTH IN CANCER: ESMO CLINICAL PRACTICE GUIDELINES

发布机构：

欧洲肿瘤内科学会

发布日期：

2020-08-05

简要介绍：

2020年8月，欧洲肿瘤内科学会(ESMO)发布了癌症患者骨健康指南，癌症本身及其治疗对骨骼健康影像很大，临床医生在治疗癌症患者时需要了解转移性疾病的多学科治疗减少骨损伤以及减少癌症治疗引起的正常骨损伤。本文主要针对维持癌症患者骨健康提供指导建议。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020 ESMO临床实践指南：癌症患者骨健康.pdf)] GetToolGuiderByIdResponse(projectId=1, id=e868f1c001958675, title=2020 ESMO临床实践指南：癌症患者骨健康, enTitle=BONE HEALTH IN CANCER: ESMO CLINICAL PRACTICE GUIDELINES, guiderFrom=Ann Oncol . 2020 Aug 5;, authorId=0, author=, summary=2020年8月，欧洲肿瘤内科学会(ESMO)发布了癌症患者骨健康指南，癌症本身及其治疗对骨骼健康影像很大，临床医生在治疗癌症患者时需要了解转移性疾病的多学科治疗减少骨损伤以及减少癌症治疗引起的正常骨损, cover=https://img.medsci.cn/2020830/1598721525773_2020535.jpg, journalId=0, articlesId=null, associationId=14, associationName=欧洲肿瘤内科学会, associationIntro=欧洲肿瘤内科学会（ESMO，European Society for Medical Oncology )是1975年成立的非盈利组织，是欧洲领先的专业组织，致力于提高肿瘤内科的专业性，推进癌症治疗和护理的多学科诊疗方法。, copyright=0, guiderPublishedTime=Wed Aug 05 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年8月，欧洲肿瘤内科学会(ESMO)发布了癌症患者骨健康指南，癌症本身及其治疗对骨骼健康影像很大，临床医生在治疗癌症患者时需要了解转移性疾病的多学科治疗减少骨损伤以及减少癌症治疗引起的正常骨损伤。本文主要针对维持癌症患者骨健康提供指导建议。</p> </div> </div> </div>, tagList=[TagDto(tagId=2813, tagName=癌症患者)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=10, categoryName=骨科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=2813, guiderKeyword=癌症患者, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3260, appHits=108, showAppHits=0, pcHits=780, showPcHits=3151, likes=0, shares=8, comments=7, approvalStatus=1, publishedTime=Sun Aug 30 01:28:54 CST 2020, publishedTimeString=2020-08-05, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Sun Aug 30 01:18:53 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 19:54:50 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 ESMO临床实践指南：癌症患者骨健康.pdf)])
2020 ESMO临床实践指南：癌症患者骨健康.pdf
下载请点击：
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1003324, encodeId=19561003324ea, content=非常有用，除了NCCN我们也需要关注其他指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd5d1590032, createdName=lizhong1981, createdTime=Wed Jul 28 14:12:32 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951553, encodeId=b8c995155305, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=22201522767, createdName=ywisyw0, createdTime=Sat Mar 27 09:21:54 CST 2021, time=2021-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892811, encodeId=7a7e89281147, content=学习一下。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201018/17516f06a53a4cf8b20993210840c5dd/8e57a4d799a845b9bc3fc17cb994a39c.jpg, createdBy=db415126199, createdName=146475c0m26(暂无昵称), createdTime=Sun Oct 18 11:39:22 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881114, encodeId=663c8811146a, content=学习了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42705312246, createdName=1488d5e7m58暂无昵称, createdTime=Mon Aug 31 05:32:41 CST 2020, time=2020-08-31, status=1, ipAttribution=)]
    2021-07-28 lizhong1981

    非常有用，除了NCCN我们也需要关注其他指南

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1003324, encodeId=19561003324ea, content=非常有用，除了NCCN我们也需要关注其他指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd5d1590032, createdName=lizhong1981, createdTime=Wed Jul 28 14:12:32 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951553, encodeId=b8c995155305, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=22201522767, createdName=ywisyw0, createdTime=Sat Mar 27 09:21:54 CST 2021, time=2021-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892811, encodeId=7a7e89281147, content=学习一下。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201018/17516f06a53a4cf8b20993210840c5dd/8e57a4d799a845b9bc3fc17cb994a39c.jpg, createdBy=db415126199, createdName=146475c0m26(暂无昵称), createdTime=Sun Oct 18 11:39:22 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881114, encodeId=663c8811146a, content=学习了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42705312246, createdName=1488d5e7m58暂无昵称, createdTime=Mon Aug 31 05:32:41 CST 2020, time=2020-08-31, status=1, ipAttribution=)]
    2021-03-27 ywisyw0

    学习一下

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1003324, encodeId=19561003324ea, content=非常有用，除了NCCN我们也需要关注其他指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd5d1590032, createdName=lizhong1981, createdTime=Wed Jul 28 14:12:32 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951553, encodeId=b8c995155305, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=22201522767, createdName=ywisyw0, createdTime=Sat Mar 27 09:21:54 CST 2021, time=2021-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892811, encodeId=7a7e89281147, content=学习一下。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201018/17516f06a53a4cf8b20993210840c5dd/8e57a4d799a845b9bc3fc17cb994a39c.jpg, createdBy=db415126199, createdName=146475c0m26(暂无昵称), createdTime=Sun Oct 18 11:39:22 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881114, encodeId=663c8811146a, content=学习了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42705312246, createdName=1488d5e7m58暂无昵称, createdTime=Mon Aug 31 05:32:41 CST 2020, time=2020-08-31, status=1, ipAttribution=)]
    2020-10-18 146475c0m26(暂无昵称)

    学习一下。

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1003324, encodeId=19561003324ea, content=非常有用，除了NCCN我们也需要关注其他指南, beContent=null, objectType=guider, channel=null, level=null, likeNumber=50, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=fd5d1590032, createdName=lizhong1981, createdTime=Wed Jul 28 14:12:32 CST 2021, time=2021-07-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=951553, encodeId=b8c995155305, content=学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=22201522767, createdName=ywisyw0, createdTime=Sat Mar 27 09:21:54 CST 2021, time=2021-03-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=892811, encodeId=7a7e89281147, content=学习一下。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20201018/17516f06a53a4cf8b20993210840c5dd/8e57a4d799a845b9bc3fc17cb994a39c.jpg, createdBy=db415126199, createdName=146475c0m26(暂无昵称), createdTime=Sun Oct 18 11:39:22 CST 2020, time=2020-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=881114, encodeId=663c8811146a, content=学习了。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=99, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=42705312246, createdName=1488d5e7m58暂无昵称, createdTime=Mon Aug 31 05:32:41 CST 2020, time=2020-08-31, status=1, ipAttribution=)]
    2020-08-31 1488d5e7m58暂无昵称

    学习了。

    0

相关指南

2019 AIOM指南：癌症患者贫血的管理

意大利肿瘤医学协会(AIOM,Italian Association of Medical Oncology) · 2020-06-02

2019 AIOM/SIN共识意见：慢性肾病或血液透析的癌症患者的靶向治疗管理

意大利肿瘤医学协会(AIOM,Italian Association of Medical Oncology) · 2019-05-31

2019 AHA科学声明：癌症患者和生存者心脏-肿瘤康复管理心血管结局

美国心脏协会(AHA,American Heart Association) · 2019-04-08

2018 SIMI意见书：癌症患者静脉血栓栓塞的预防和治疗

意大利内科学会(SIMI,Italian Society of Internal Medicine) · 2018-10-01

2018 JSPM临床指南：癌症患者泌尿系统症状的治疗建议

日本姑息医学会(JSPM,Japanese Society of Palliative Medicine) · 2018-10-05

2018 JSCO临床实践指南：儿童，青少年以及青年癌症患者生育能力保留

日本临床肿瘤学会(JSCO,Japan Society of Clinical Oncology) · 2018-03-26

拓展阅读

2016 CCO临床实践指南：癌症患者抑郁的管理

加拿大安大略癌症治疗中心(CCO,Cancer Care Ontario) · 2016-07-15

2013 国际临床实践指南：癌症患者中心静脉导管血栓形成的治疗和预防

国际血栓形成和癌症创议(ITAC-CME,International Initiative on Thrombosis and Cancer) · 2013-01-01

重视癌症患者贫血，早期筛查与治疗铁缺乏——欧洲《成年癌症患者铁缺乏的管理意见书》解读

暂未更新 · 2018-01-30

2018 临床实践指南：青春期后女性癌症患者生育能力保留

国外肿瘤科相关专家小组（统称） · 2018-01-08

2018 ESMO临床实践指南：癌症患者贫血和铁缺乏的管理

欧洲肿瘤内科学会(ESMO,European Society for Medical Oncology) · 2018-02-20

2018 JSCO临床实践指南：儿童，青少年以及青年癌症患者生育能力保留

日本临床肿瘤学会(JSCO,Japan Society of Clinical Oncology) · 2018-03-26